Followers | 507 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Monday, June 28, 2021 12:22:24 AM
well recently it ran up fast then meandered back to half the peak value, this is the fairly common 50% fibonacci retracement tool level that's still ok bullish (they can bounce off the 61.8% level then otherwise the trend might be bearish, and bounces off 38.2% indicates a strong trend)
then it held its ground and is going back up some more, this makes me immediately look for a bull flag on the charts
there is a nice one on the weekly log chart with a price target in the thousands or hundreds perhaps, time is money so get paid to wait that's what I say
then look at the big chart at the end it's an inverted head and shoulders bottom, thankful my scans are catching that breakout this far out in charts
because the large time scale means the rally will be both high percentage and continue to produce results repeatedly and for a very long time
plus buying on margin you can get 1.5x extra leverage for profits putting debt and money to work for you
as well long term options, spreads, cash secured puts might also be considered
https://www.cassavasciences.com/
https://finance.yahoo.com/quote/SAVA/profile?p=SAVA
https://www.barchart.com/stocks/quotes/SAVA
https://finviz.com/quote.ashx?t=SAVA
https://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=SAVA
https://stockcharts.com/c-sc/sc?chart=SAVA,uu[e,a]dhclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20][iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!lf14][j20444984,y]&r=3555b
https://www.barchart.com/etfs-funds/quotes/SAVA/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=TREND&sym=SAVA&grid=1&height=500&studyheight=100&timeframe=2%20Months
normal chart
log chart
normal chart
log chart
Recent SAVA News
- Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam • GlobeNewswire Inc. • 05/10/2024 08:02:00 PM
- Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution • GlobeNewswire Inc. • 05/08/2024 03:00:00 PM
- Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ • GlobeNewswire Inc. • 05/01/2024 01:10:00 PM
- Redemption Date Announced for Warrants • GlobeNewswire Inc. • 04/15/2024 01:20:00 PM
- Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials • GlobeNewswire Inc. • 03/25/2024 01:13:00 PM
- Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference • GlobeNewswire Inc. • 03/04/2024 02:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 09:01:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:22:12 PM
- Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates • GlobeNewswire Inc. • 02/28/2024 02:14:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 02:20:27 PM
- No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months • GlobeNewswire Inc. • 02/07/2024 02:08:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/01/2024 09:00:47 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:23:45 PM
- Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders • GlobeNewswire Inc. • 01/05/2024 02:12:00 PM
- Form CERT - Certification by an exchange approving securities for listing • Edgar (US Regulatory) • 01/03/2024 09:24:43 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 01/03/2024 09:22:52 PM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 01/03/2024 09:18:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 02:10:10 PM
- Form 8-A12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 02:10:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:19:07 PM
- Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders • GlobeNewswire Inc. • 12/12/2023 02:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:18:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:06:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:57:42 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM